A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

Clinical trial NCT05059223 · COMPLETED

Trial details

NCT number: NCT05059223
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Cataplexy Excessive Daytime Sleepiness

Start date: 2021-09-15
Primary completion: 2024-03-15
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.